Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study.

Saved in:
Bibliographic Details
Title: Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study.
Authors: Chun SJ; Department of Radiation Oncology, Ilsan Dongguk University Hospital, Goyang, the Republic of Korea., Kim N; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea., Lim DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, the Republic of Korea., Kim JY; Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, the Republic of Korea., Wee CW; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.; Brain Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea., Yoon HI; Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea.; Brain Research Institute, Yonsei University College of Medicine, Seoul, the Republic of Korea., Jeon SH; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, the Republic of Korea., Kim IA; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, the Republic of Korea., Lee JH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, the Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, the Republic of Korea.; Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, the Republic of Korea.
Source: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2026 May 26; Vol. 59, pp. 101197. Date of Electronic Publication: 2026 May 26 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology Country of Publication: Ireland NLM ID: 101713416 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6308 (Electronic) Linking ISSN: 24056308 NLM ISO Abbreviation: Clin Transl Radiat Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-6308
DOI:10.1016/j.ctro.2026.101197